Why is Bliss GVS Pharma falling/rising?

As of 16-Sep, Bliss GVS Pharma Ltd is currently priced at 151.45, reflecting a decrease of 0.75, or 0.49%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 1.85% during this period. Additionally, the stock's performance over the past week shows a decrease of 1.43%, and it has underperformed its sector by 0.77% today. Although the stock has a low debt-to-equity ratio and has generated a return of 12.81% over the past year, its profits have decreased by 3.6%, indicating potential concerns regarding its profitability despite consistent returns over the last three years.
Broader market context indicates that while the stock has struggled recently, the Sensex has gained 1.58% over the past week, highlighting a stark contrast between the stock's performance and the broader market. The stock's year-to-date performance shows a decline of 8.02%, while the Sensex has increased by 5.43% during the same period. This divergence suggests that investor sentiment may be shifting away from Bliss GVS Pharma, particularly as indicated by the falling investor participation and a significant drop in delivery volume.